l-carnitine and citalopram Frontiers Carnitine. L-Carnitine Fumarate – Olympian Labs

Guo RB, Sun PL, Zhao AP, Gu J, Ding X, Qi J, Sun XL, Hu G

PMID: 24780874

All support the notion that Kir4.1 dysfunction facilitates neuronal hyperexcitability and is likely to contribute to epilepsy, thus warranting more detailed studies to reveal the role of Kir4.1 in epilepsy

This approach allowed them to assess the functional impact of thousands of previously unclear genetic changes, known as variants of unknown significance, and determine whether they were benign or pathogenic (92)Huang H, et al

Care 15, 122126

The "gradual decline" group (approximately 40-50% of users) represents modal experience where benefits slowly regress toward pre-treatment baseline over 4-8 months, typically affecting users who completed shorter treatment courses (2-4 months), used lower concentrations or inconsistent application, possessed moderate to severe baseline skin damage requiring ongoing support, maintained adequate but not optimal complementary skincare, experienced significant lifestyle stressors affecting skin health including poor sleep or high stress, and faced genetic or age-related collagen production limitations